Cassandra Celatka

USPTO Granted Patents = 19 (Patent Applications = 9)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 12)

Average Co-Inventor Count = 7.5

ph-index = 6

Forward Citations = 85(Granted Patents)

Location History:

Waltham, MA (US) (2014)
Hull, MD (US) (2018 - 2022)
Hull, MA (US) (2009 - 2024)

Company Filing History:

Imago Biosciences, Inc.

Massachusetts Institute of Technology

where one patent can have more than one assignee

Years Active: 2009-2024

Loading Chart...

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12060349 - Glucosylceramide synthase inhibitors (2024-08-13),

2. 11932629 - KDM1A inhibitors for the treatment of disease (2024-03-19),

3. 11773068 - KDM1A inhibitors for the treatment of disease (2023-10-03),

4. 11578059 - KDM1A inhibitors for the treatment of disease (2023-02-14),

5. 11390590 - Methods and processes for the preparation of KDM1A inhibitors (2022-07-19),

6. 11230534 - KDM1A inhibitors for the treatment of disease (2022-01-25),

7. 11008316 - Glucosylceramide synthase inhibitors (2021-05-18),

8. 10519118 - KDM1A inhibitors for the treatment of disease (2019-12-31),

9. 9981922 - KDM1A inhibitors for the treatment of disease (2018-05-29),

10. 9745294 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2017-08-29),

11. 9744153 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2017-08-29),

12. 9272996 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2016-03-01),

13. 8980926 - 2-aminoindole compounds and methods for the treatment of malaria (2015-03-17),

14. 8940776 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2015-01-27),

15. 8703811 - [object Object] (2014-04-22),

Title: Innovations and Contributions of Cassandra Celatka

Introduction

Cassandra Celatka, a notable inventor based in Hull, MA, has made significant strides in the field of biotechnology, particularly in developing innovative treatments for various diseases. With an impressive portfolio of 19 patents, Celatka stands out as a key figure in the medical research community.

Latest Patents

Among her most recent inventions are groundbreaking patents related to glucosylceramide synthase inhibitors. This invention pertains to inhibitors of glucosylceramide synthase (GCS) that are represented by a specific structural formula, which are useful in treating metabolic diseases, including lysosomal storage diseases, as well as cancers. Another notable patent involves KDM1A inhibitors, aimed at treating or preventing diseases like acute myelogenous leukemia. This patent outlines various methods of inhibiting KDM1A, increasing gamma globin gene expression, and inducing differentiation in cancer cells.

Career Highlights

Cassandra has had a remarkable career, with significant contributions while working at prominent companies such as Genzyme Corporation and Imago Biosciences, Inc. Her expertise in biochemistry and molecular biology has allowed her to lead various innovative projects that focus on creating novel therapeutic solutions.

Collaborations

Throughout her career, Celatka has collaborated with various professionals in the field, including notable coworkers Yibin Xiang and Cecilia M Bastos. Together, they have worked on cutting-edge research and development, pushing the boundaries of current medical treatments and contributing to advancements in healthcare.

Conclusion

Cassandra Celatka's work is a testament to the impact of innovative thinking in addressing complex health issues. With her continued dedication to research and development, she is poised to make even more significant contributions to the field of biotechnology and medicine. Her numerous patents reflect not only her ingenuity as an inventor but also her commitment to improving patient outcomes through innovative treatments.

This text is generated by artificial intelligence and may not be accurate.